SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management

References

• Riggs J. E. Longitudinal Gompertzian analysis of ALS mortality in the United States 1977–1986: evidence for an inherently susceptible subset. Mech Ageing Dev 1990; 55: 207–20
   PubMed Web of Science ®Google Scholar
• Neilson S., Robinson I., Clifford Rose F., Hunter M. Rising mortality from motor neuron disease: an explanation. Acta Neurol Scand 1993; 87: 184–91
   PubMedGoogle Scholar
• Neilson S., Gunnarsson L. ‐G., Robinson I. Rising mortality from motor neuron disease in Sweden 1961–1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 1994; 90: 150–9
   PubMed Web of Science ®Google Scholar
• Strong M. J., Hudson A. J., Alvord W. G. Familial amyotrophic lateral sclerosis, 1850−1989: a statistical analysis of the world literature. Can J Neurol Sci 1991; 18: 45–58
   PubMed Web of Science ®Google Scholar
• Williams D. B., Floate D. A., Leicester J. Familial motor neuron disease: differing penetrance in large pedigrees. J Neurol Sci 1988; 86: 215–30
   PubMed Web of Science ®Google Scholar
• Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Andersen P. M., Nilsson P., Ala‐Hurula V., Keränen M. ‐L., Tarvainen I., Haltia T., et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in Cu/Zn superoxide dismutase. Nat Genet 1995; 10: 61–6
   PubMed Web of Science ®Google Scholar
• Mezei M., Andersen P. M., Stewart H., Weber M., Eisen A. Motor system abnormalities in heterozygous relatives of a D90A homozygous Cu/Zn SOD ALS patient of Finnish extraction. J Neurol Sci 1999; 169: 49–55
   PubMedGoogle Scholar
• Andersen P. M., Sims K. B., Xin W. W., Kiely R., O'Neill G., Ravits J., et al. Sixteen novel mutations in the gene encoding Cu/Zn superoxide dismutase in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 2: 62–73
   Web of Science ®Google Scholar
• Haverkamp L. J., Appel V., Appel S. H. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118: 707–19
   PubMed Web of Science ®Google Scholar
• Li T. ‐M., Alberman E., Swash M. Comparison of sporadic and familial disease among 580 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 1988; 51: 778–84
   PubMed Web of Science ®Google Scholar
• Forsgren L., Almay B. G., Holmgren G., Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68: 20–9
   PubMed Web of Science ®Google Scholar
• Eisen A., Schulzer M., MacNeil M., Pant B., Mak E. Duration of amyotrophic lateral sclerosis is age dependent. Muscle & Nerve 1993; 16: 27–32
   PubMed Web of Science ®Google Scholar
• Traynor B. J., Alexander M., Corr B., Frost E., Hardimann O. Effects of a multidisciplinary ALS clinic on survival. J Neurol Neurosurg Psychiatry 2003; 74: 1258–61
   PubMed Web of Science ®Google Scholar
• Lee J. R. J., Annegers J. F., Appel S. Prognosis of ALS and the effects of referral selection. J Neurol Sci 1995; 132: 207–15
   PubMed Web of Science ®Google Scholar
• Belsh J. M., Schiffman P. L. The amyotrophic lateral sclerosis (ALS) patient perspective on misdiagnosis and it repercussions. J Neurol Sci 1996; 139((Suppl))110–6
   PubMed Web of Science ®Google Scholar
• Davenport R. J., Swingler R. J., Chancellor A. M., Warlow C. P. Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 1996; 60: 147–51
   PubMed Web of Science ®Google Scholar
• Brooks B. R. Earlier is better: the benefits of early diagnosis. Neurology 1999; 53((Suppl 5))S53–4
   Google Scholar
• Traynor B. J., Codd M. B., Corr B., Forde C., Frost E., Hardiman O. Amyotrophic lateral sclerosis mimic syndromes. Arch Neurol 2000; 57: 109–13
   PubMed Web of Science ®Google Scholar
• Boukaftane Y., Khoris J., Moulard B., Salachas F., Meininger V., Malafosse A., et al. Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis. Can J Neurol Sci 1998; 25: 192–6
   PubMed Web of Science ®Google Scholar
• Niemann S., Joos H., Meyer T., Vielhaber S., Reuner U., Gleichmann M., et al. Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect. J Neurol Neurosurg Psychiatry 2004; 75: 1186–8
   PubMed Web of Science ®Google Scholar
• Battistini S., Giannini F., Greco G., Bibbò G., Ferrera L., Marini V., et al. SOD1 mutations in amyotrophic lateral sclerosis: results from a multicentre Italian study. J Neurol 2005; 252: 782–8
   PubMed Web of Science ®Google Scholar
• Andersen P. M., Nilsson P., Keränen M. ‐L., Forsgren L., Hägglund J., Karlsborg M., et al. Phenotypic heterogeneity in MND patients with Cu/Zn superoxide dismutase mutations in Scandinavia. Brain 1997; 10: 1723–37
   Web of Science ®Google Scholar
• Garcia‐Redondo A., Bustos F., Juan Y Seva B., Del Hoyo P., Jiménez S., Campos Y., et al. Molecular analysis of the superoxide dismutase 1 gene in Spanish patients with sporadic or familial amyotrophic lateral sclerosis. Muscle Nerve 2002; 26: 274–8
   PubMed Web of Science ®Google Scholar
• Orrell R. W., Habgood J. J., Gardiner I., King A. W., Bowe F. A., Hallewell R. A., et al. Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for Cu/Zn superoxide dismutase in UK families with amyotrophic lateral sclerosis. Neurology 1997; 48: 746–51
   PubMed Web of Science ®Google Scholar
• Shaw C. E., Enayat Z. E., Chioza B. A., Al‐Chalabi A., Radunovic A., Powell J. F., et al. Mutations in all five exons of SOD1 may cause ALS. Ann Neurol 1998; 43: 390–4
   PubMed Web of Science ®Google Scholar
• Jackson M., Al‐Chalabi A., Enayat Z. E., Chioza B., Leigh P. N., Morrison K. E. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation. Ann Neurol 1997; 42: 803–7
   PubMed Web of Science ®Google Scholar
• Gellera C. Genetics of ALS in Italian families. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2((Suppl 1))S43–6
   Web of Science ®Google Scholar
• Jones C. T., Swingler R. J., Simpson S. A., Brock D. J. Superoxide dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32: 290–2
   PubMed Web of Science ®Google Scholar
• Cudkowicz M. E., McKenna‐Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 210–21
   PubMed Web of Science ®Google Scholar
• Juneja T., Pericak‐Vance M. A., Laing N. G., Dave S., Siddique T. Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu/Zn superoxide dismutase. Neurology 1997; 48: 55–7
   PubMed Web of Science ®Google Scholar
• Suthers G., Laing N., Wilton S., Dorosz S., Waddy H. ‘Sporadic’ motor neuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994; 344: 1773
   PubMedGoogle Scholar
• Orrell R. W., Habgood J. J., Malaspina A., Mitchell J., Greenwood J., Lane R. J., et al. Clinical characteristics of SOD1 gene mutations in UK families with ALS. J Neurol Sci 1999; 169: 56–60
   PubMed Web of Science ®Google Scholar
• Stewart H. G., Mackenzie I., Eisen A., Brännström T., Marklund S. L., Andersen P. M. Clinicopathological phenotype of ALS with a novel G72C SOD1 gene mutation mimicking a myopathy. Muscle Nerve 2006; 33: 701–6
   PubMed Web of Science ®Google Scholar
• Chio A. Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis. J Neurol 1999; 246((Suppl 3))1–5
   Google Scholar
• Chio A. Update on ISI survey: Europe, North America and South America. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1((Suppl 1))S9–11
   Google Scholar
• Andersen P. M., Forsgren L., Binzer M., Nilsson P., Ala‐Hurula V., Keränen M. L., et al. Autosomal recessive adult‐onset ALS associated with homozygosity for Asp90Ala Cu/Zn superoxide dismutase mutation. A clinical and genealogical study of 36 patients. Brain 1996; 119: 1153–72
   PubMed Web of Science ®Google Scholar
• Khoris J., Moulard B., Briolotti V., Hayer M., Durieux A., Clavelou P., et al. Coexistence of dominant and recessive familial amyotrophic lateral sclerosis with the D90A Cu/Zn superoxide dismutase mutation within the same country. Eur J Neurol 2000; 7: 207–11
   PubMedGoogle Scholar
• Winter S. M., Claus A., Oberwittler C., Volkel H., Wenzler S., Ludolph A. C. Recessively inherited amyotrophic lateral slerosis: a German family with the D90A Cu/Zn SOD mutation. J Neurol 2000; 247: 783–6
   PubMedGoogle Scholar
• Skvortsova V. I., Limborska S. A., Slominsky P. A., Levitskaya N. I., Levitsky G. N., Shadrina M. I., et al. Sporadic ALS associated with the D90A Cu/Zn superoxide dismutase mutation in Russia. Eur J Neurol 2001; 8: 167–72
   PubMed Web of Science ®Google Scholar
• Cudkowicz M. E., McKenna‐Yasek D., Chen C., Hedley‐Whyte E. T., Brown RH J. r. Limited corticospinal tract involvement in amyotrophic lateral sclerosis subjects with the A4V mutation in the Cu/Zn superoxide dismutase gene. Ann Neurol 1998; 43: 703–10
   PubMed Web of Science ®Google Scholar
• Brooks B. R., Miller R. G., Swash M., Munsat T. L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• Andersen P. M., Borasio G. D., Dengler R., Hardiman O., Kollewe K., Leigh P. N., et al. EFNS Task Force on Management of Amyotrophic Lateral Sclerosis. Guidelines for diagnosing and clinical care of patients and relatives. An evidence‐based review with Good Practice Points. Eur J Neurol 2005; 12: 921–38
   PubMed Web of Science ®Google Scholar
• Timman R., Roos R., Maat‐Kievit A., Tibben A. Adverse effects of predictive testing for Huntington's disease underestimated: long‐term effects 7–10 years after the test. Health Psychology 2004; 23: 189–97
   PubMed Web of Science ®Google Scholar